Intriguingly, aberrantly expressed JunB facilitates the progression of ccRCC, multiple myeloma, and several lymphomas through transcriptionally promoting the production of chemokines, inflammatory cytokines, and growth factors within the TME. Here, JUNB is linked to AL amyloidosis.